Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05283499 · ClinicalTrials.gov registry record · Phase 3
Opioid Analgesic Reduction Study (OARS) - Pilot
A Phase 3 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 3
- Development phase
- 53
- Enrollment target
NCT05283499 is a Phase 3 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 53 participants.
The verdict
NCT05283499, a Phase 3 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this study is to test protocols being developed for the conduct of a large sale multi-site clinical trial which will compare opioids to non-opioids for managing post-surgical impacted 3rd molar extraction pain.
Interventions
- DRUG OPIOID
- DRUG NON-OPIOID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2020-07-06 |
| Est. Completion | 2021-03-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05283499
The ClinicalTrials.gov registry entry for NCT05283499 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OPIOID is the first listed.
NCT05283499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05283499 about?
NCT05283499 is a clinical study titled "Opioid Analgesic Reduction Study (OARS) - Pilot". The purpose of this study is to test protocols being developed for the conduct of a large sale multi-site clinical trial which will compare opioids to non-opioids for managing post-surgical impacted 3rd molar extraction pain.
What is the current status of trial NCT05283499?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 53 participants. The study started on 2020-07-06. Estimated completion is 2021-03-26.
What interventions are being tested in trial NCT05283499?
The interventions under investigation include: OPIOID (DRUG), NON-OPIOID (DRUG).
Who is sponsoring clinical trial NCT05283499?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.